Review of the use of defined daily dose concept in drug utilisation research in China

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 10, 2012, Pages 1118-1124

  Teng, Lida ^a   Xin, Hua wen ^b   Blix, Hege Salvesen ^c   Tsutani, Kiichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

ATC DDD; Defined daily dose; Drug utilisation research

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHINESE DRUG; GASTROINTESTINAL AGENT; IMMUNOMODULATING AGENT; INSECTICIDE; RESPIRATORY TRACT AGENT; SEX HORMONE;

CHINA; DAILY DOSE COST; DATA BASE; DEFINED DAILY DOSE CONCEPT; DRUG METABOLISM; DRUG RESEARCH; DRUG UTILISATION INDEX; DRUG UTILISATION RESEARCH; DRUG UTILIZATION; HERBAL MEDICINE; HOSPITAL; HUMAN; MEDICAL LITERATURE; MEDICAL PARAMETERS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

CHINA; CLINICAL PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG UTILIZATION; HUMANS; NUTRITION POLICY;

EID: 84867143770     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3240     Document Type: Review

References (24)

1. World Health Organization (WHO). Introduction to drug utilization research. WHO: Oslo, 2003.
2. WHO. Guidelines for ATC classification and DDD assignment (13th edn). WHO: Oslo, 2010.
3. Wettermark B, Vlahovic-palcevski V, et al. Drug Utilization Research. In Pharmacoepidemiology and Therapeutic Risk Management, Hartzema AG, Tilson HH, et al (eds). Harvey Whitney Books Company: USA, 2008.
4. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/ (accessed 17 October, 2010).
5. Ji JD. Jing Shen Yao Wu Li Yong Yan Jiu De Qing Kuang Jian Jie (Introduction of current drug utilisation studies of psychosis medication). Zhong Guo Yao Wu Yi Lai Xing Zha Zhi (Chinese Journal of Drug Dependence) 1988; 2(3): 8-9. (in Chinese).
6. Cha ZL, Zhang Y. Yao Wu Li Yong Yan Jiu (Drug utilisation research). Yao Wu Liu Xing Bing Xue Za Zhi (Chinese Journal of Pharmacoepidemiology) 1996; 5(2): 112-117. (in Chinese).
7. Capella D, Fu Y, et al. Yao Wu Li Yong Yan Jiu De Miao Shu Gong Ju He Fen Xi Fang Fa (Description tool and analysis method in drug utilisation research). Yao Wu Liu Xing Bing Xue Za Zhi (Chinese Journal of Pharmacoepidemiology) 1997; 6(3): 170-181. (in Chinese).
8. Zou H, Shao YF, et al. Yi Yuan Yao Pin DDD Shu Pai Xu Fen Xi De Yuan Li Ji Li Yong (The principle and utilization of sequential analysis of DDD system of drug in hospitals). Zhong Guo Yao Fang (Journal of China Pharmacy) 1996; 7(5): 215-217. (in Chinese).
9. Pharmacopoeia Commission of the Chinese Ministry of Public Health. The Pharmacopoeia of the People's Republic of China (in Chinese) 1985-2005 editions 1985; 1990; 1995; 2000; 2005.
10. Xin Bian Yao Wu Xue (New Materia Medica) (in Chinese) (12th-16th edns). People's Medical Publishing House: Beijing. 1985(12th); 1992(13th); 1998(14th); 2003(15th); 2006(16th).
11. Zhang W, Shen X, et al. Antibiotic use in five children's hospitals during 2002-2006: the impact of antibiotic guidelines issued by the Chinese Ministry of Health. Pharmacoepidemiol Drug Saf 2008; 17(3):306-311.
12. Zhang W, Shen X, et al. Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children's hospitals. Eur J Clin Pharmacol 2008; 64(8):821-828.
13. Pharmacopoeia Commission of the Chinese Ministry of Public Health. Lin Chuang Yong Yao Xu Zhi (Clinical guide to the Chinese pharmacopoeia) (in Chinese) 2000-2005 edicions 2000; 2005.
14. Goossens H, Ferech M, Vander Stichele R, Elseviers M, and the ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365(9459): 579-587.
15. Ansari F, Erntell M, et al. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009; 49(10):1496-1504.
16. McClean P, Hughes C, Tunney M, Goossens H, Jans B; on behalf of the European Surveillance of Antimicrobial Consumption (ESAC) Nursing Home Project Group. Antimicrobial prescribing in European nursing homes. J Antimicrob Chemother 2011; 66(7):1609-1616.
17. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357(9271):1851-1853..
18. Wang Q, Jin Y, et al. Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Dose (DDD). (in Chinese) Chinese Academy of Medical Sciences & Peking Union Medical College Press: Beijing, 2003.
19. Rønning M, Blix HS, et al. Problems in collecting comparable national drug use data in Europe: the example of antibacterials. Eur J Clin Pharmacol 2003; 58(12):843-849.
20. Zhen YH, Wang YZ. Wo Yuan 2004-2007 Nian Zhong Yao Zhu She Ji De Shi Yong Ji Bu Liang Fan Ying Qing Kuang Fen Xi (The utilisation of Chinese herbal injections in our hospital in 2004-2007 and the analysis of associated adverse drug reactions). Yao Wu Liu Xing Bing Xue Za Zhi (Chinese Journal of Pharmacopeidemiolgy) 2009; 18(4): 276-278. (in Chinese).
21. Mei N, Li GH, et al. 123 Li Zhong Cheng Yao Bu Liang Fan Ying Bao Gao Fen Xi (The analysis of 123 cases of adverse drug reactions associated with Chinese Patent Medicine). Zhong Guo Zhong Yao Za Zhi (China Journal of Chinese Matera Medica) 2008; 33(13):1268-30. (in Chinese).
22. Ji K, Chen J, et al. Comments on serious anaphylaxis caused by nine Chinese herbal injections used to treat common colds and upper respiratory tract infections. Regul Toxicol Pharmacol 2009; 55(2): 134-138
23. WHO Uppsala Monitoring Centre (UMC). Guidelines for herbal ATC classification. WHO: Uppsala, 2004.
24. Tsutani K, Takuma H. Regulatory sciences in herbal medicines and dietary supplements. Yakugaku Zasshi (Journal of the Pharmaceutical Society of Japan) 2008; 128(6): 867-880. (in Japanese).